Steve Schonfeld’s Applied Therapeutics APLT Stock Holding History

Steve Schonfeld’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-196,660	Closed	-$61.2K	–	2179
2025 Q2	$61.2K	Sell	196,660 -4,476,953	-96%	-$1.73M	﹤0.01%	1867
2025 Q1	$2.28M	Sell	4,673,613 -4,088,678	-47%	-$2.41M	0.01%	898
2024 Q4	$7.5M	Buy	8,762,291 +8,419,781	+2,458%	+$52.8M	0.04%	387
2024 Q3	$2.91M	Sell	342,510 -191,219	-36%	-$1.13M	0.02%	738
2024 Q2	$2.49M	Sell	533,729 -1,302,913	-71%	-$6.17M	0.02%	812
2024 Q1	$12.5M	Buy	1,836,642 +1,345,151	+274%	+$6.04M	0.08%	295
2023 Q4	$1.65M	Buy	491,491 +34,091	+7%	+$84.8K	0.01%	868
2023 Q3	$1.14M	Buy	+457,400	New	+$754K	0.01%	980
2022 Q2	–	Sell	-30,500	Closed	-$65K	–	2510
2022 Q1	$65K	Buy	+30,500	New	+$81.7K	﹤0.01%	2304

Other funds holding APLT

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Steve Schonfeld's APLT Position: Q3 2025 in Review

Steve Schonfeld sold out of Applied Therapeutics (APLT) in Q3 2025, closing a stake of 196,660 shares — an estimated $61.2K sold.

Steve Schonfeld first reported a position in APLT in Q1 2022 and held it in 9 quarters. The position peaked at $12.5M in Q1 2024. 70 funds tracked by Wall St. Rank hold APLT as of Q3 2025.

Steve Schonfeld reported no remaining Applied Therapeutics position as of Q3 2025 after selling out during the quarter.
Steve Schonfeld sold 196,660 Applied Therapeutics shares in Q3 2025, an estimated $61.2K.
Steve Schonfeld first reported a position in Applied Therapeutics in Q1 2022 and held it in 9 quarters.
Steve Schonfeld's Applied Therapeutics position peaked at $12.5M in Q1 2024.
70 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.